Effectiveness of electro-press needle for menopause-associated hot flashes: Protocol of a randomized controlled trial

Shudan Yu, Xin He, Hangyu Shi, Yu Chen, Zhishun Liu, Shudan Yu, Xin He, Hangyu Shi, Yu Chen, Zhishun Liu

Abstract

Background: Hot flashes (HF) are a prevalent symptom associated with menopause affecting up to 85% of women aged 40 to 65 years. Previous studies indicated that acupuncture might relieve the symptom of HF significantly; however, its effectiveness has not been clarified quantitatively. Electro-press needles (EPN) is a novel acupuncture that combines a shallow tiny needle with an electrical transdermal stimulator. Either the needle or the electrical stimulator could function in the treatment. This study aims to evaluate the effectiveness of EPN in comparison with no intervention in relieving HF of perimenopausal and postmenopausal women.

Methods/design: This study will be a 2-arm randomized waitlist controlled trial. According to the ratio of 1:1 and block randomization, a total of 122 patients with moderate or severe HF will be randomly allocated to either EPN group or waitlist control group. The EPN group will receive 3 sessions of EPN treatment each week in consecutive 6 weeks, 18 sessions in total. The waitlist control group will get no intervention over the first 6 weeks. All the patients will be followed up in the next 24 weeks. The primary outcome will be the percentage of the participants whose 24-hour mean HF is 50% less than the baseline at Week 6. Secondary outcomes will include HF score, HF frequency, HF severity, the Menopause Rating Scale and Menopause-Specific Quality of Life Questionnaire Score.

Discussion: This study will evaluate the effectiveness and safety of EPN treatment to alleviate HF symptoms in perimenopausal and postmenopausal women, excluding self-healing factors. The limitations of the trial design are its single-center scope, lack of placebo control and impossible to blind the acupuncturists and patients.Trial registration: This clinical trial has been registered in Clinical Trial Registry (registration number: NCT04995107; date of registration: Aug 6, 2021).

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Figures

Figure 1
Figure 1
Flow chart of participants through the proposed trial. ∗ The Waitlist control group can receive 6 weeks EPN therapy as compensatory at weeks 7.
Figure 2
Figure 2
Acupoints diagram.
Figure 3
Figure 3
EPN and electrical device. EPN = electro-press needle.

References

    1. Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause—global prevalence, physiology and implications. Nat Rev Endocrinol 2018;14:199–215.
    1. ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol 2014;123:202–16. doi: 10.1097/01.AOG.0000441353.20693.78. Erratum in: Obstet Gynecol. 2016 Jan;127(1):166. Erratum in: Obstet Gynecol. 2018 Mar;131(3):604.
    1. Tepper PG, Brooks MM, Randolph JF, Jr, et al. . Characterizing the trajectories of vasomotor symptoms across the menopausal transition. Menopause 2016;23:1067–74.
    1. Silveira JS, Clapauch R, Souza Md, Bouskela E. Hot flashes: emerging cardiovascular risk factors in recent and late postmenopause and their association with higher blood pressure. Menopause 2016;23:846–55.
    1. Stuenkel CA, Davis SR, Gompel A, et al. . Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2015;100:3975–4011.
    1. Sassarini J, Lumsden MA. Non-hormonal management of vasomotor symptoms. Climacteric 2013;16: (suppl 1): 31–6.
    1. Ee C, French SD, Xue CC, Pirotta M, Teede H. Acupuncture for menopausal hot flashes: clinical evidence update and its relevance to decision making. Menopause 2017;24:980–7.
    1. Ee C, Xue C, Chondros P, et al. . Acupuncture for menopausal hot flashes: a randomized trial. Ann Intern Med 2016;164:146–54.
    1. Liu Z, Ai Y, Wang W, et al. . Acupuncture for symptoms in menopause transition: a randomized controlled trial. Am J Obstet Gynecol 2018;219:373.e1–0.
    1. Li L, Xu L, Wu J, Dong L, Lv Y, Zheng Q. Quantitative analysis of placebo response and factors associated with menopausal hot flashes. Menopause 2017;24:932–7.
    1. Chae Y, Lee YS, Enck P. How placebo needles differ from placebo pills? Front Psychiatry 2018;9:243.
    1. Avis NE, Levine BJ, Danhauer S, Coeytaux RR. A pooled analysis of three studies of nonpharmacological interventions for menopausal hot flashes. Menopause 2019;26:350–6.
    1. Gaspard U, Taziaux M, Mawet M, et al. . A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety. Menopause 2020;27:848–57.
    1. Guttuso T, Jr, DiGrazio WJ, Reddy SY. Review of hot flash diaries. Maturitas 2012;71:213–6.
    1. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol 2001;19:4280–90.
    1. Anderson DJ, Chung HF, Seib CA, et al. . Obesity, smoking, and risk of vasomotor menopausal symptoms: a pooled analysis of eight cohort studies. Am J Obstet Gynecol 2020;222:478.e1–7.
    1. Butt DA, Deng LY, Lewis JE, Lock M. Minimal decrease in hot flashes desired by postmenopausal women in family practice. Menopause 2007;14:203–7.
    1. Pinkerton JV, Constantine G, Hwang E, Cheng RF. Study 3353 Investigators. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial. Menopause 2013;20:28–37.
    1. Berlin Center for Epidemiology and Health Research. MRS-the Menopause Rating Scale. Available at: . Accessed June 20, 2013. 17.
    1. Heinemann LA, DoMinh T, Strelow F, Gerbsch S, Schnitker J, Schneider HP. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes 2004;2:67.
    1. Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas 2005;50:209–21.
    1. Hilditch JR, Lewis J, Peter A, et al. . A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161–75.
    1. Li Y, Zheng H, Zheng Q, et al. . Use acupuncture to relieve perimenopausal syndrome: study protocol of a randomized controlled trial. Trials 2014;15:198.
    1. Li QL. Clinical study of a new type of acupuncture for the treatment of insomnia in perimenopause. SiChuan J Traditional Chinese Med 2017;35:202–4.
    1. Yan XH, Chen JJ, Yan LR, Yang QL, Liu XJ, Su XJ. Effects of electric stimulation combined with auricular acupoint pressing on anxiety and depression symptoms, quality of life and neurotransmitters in patients with perimenopausal syndrome. HeBei Med 2020;42: 562-564+568.
    1. Tan R, He Y, Zhang S, Pu D, Wu J. Effect of transcutaneous electrical acupoint stimulation on protecting against radiotherapy- induced ovarian damage in mice. J Ovarian Res 2019;12:65.
    1. Avis NE, Coeytaux RR, Isom S, Prevette K, Morgan T. Acupuncture in Menopause (AIM) study: a pragmatic, randomized controlled trial. Menopause 2016;23:626–37.
    1. Zhou J, Qu F, Sang X, Wang X, Nan R. Acupuncture and auricular acupressure in relieving menopausal hot flashes of bilaterally ovariectomized Chinese women: a randomized controlled trial. Evid Based Complement Alternat Med 2011;713274.
    1. Moffet HH. Sham acupuncture may be as efficacious as true acupuncture: a systematic review of clinical trials. J Altern Complement Med 2009;15:213–6.
    1. Zhang CS, Tan HY, Zhang GS, Zhang AL, Xue CC, Xie YM. Placebo devices as effective control methods in acupuncture clinical trials: a systematic review. PLoS One 2015;10:e0140825.
    1. Kim TH, Lee MS, Alraek T. Acupuncture for the management of menopausal and perimenopausal symptoms: current clinical evidence and perspectives for future research. Maturitas 2017;100:82–3.
    1. Chen ZX, Li Y, Zhang XG, et al. . Sham electroacupuncture methods in randomized controlled trials. Sci Rep 2017;7:40837.
    1. Iliodromiti S, Wang W, Lumsden MA, et al. . Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review. BJOG 2020;127:320–33.
    1. Pirotta M, Ee C, Teede H, et al. . Acupuncture for menopausal vasomotor symptoms: study protocol for a randomised controlled trial. Trials 2014;15:224.doi: 10.1186/1745-6215-15-224. Erratum in: Trials. 2015;16:89.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe